KMDA · Kamada Ltd · Webcasts, Transcripts & Audio
$7.90
-0.15 (-1.86%)
At close · Oct 28
Return incl. dividend (before tax)
Q1 2026 earnings call transcript
Market Cap
$464.57M
Shares
57.71M
Volume · Oct 28
50.29K
Avg daily vol (3M)
123.95K
Kamada Ltd Webcasts
Earnings calls, investor updates, investor days and conferences for Kamada Ltd (KMDA), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q2
2026-08-12
Kamada Ltd (KMDA) Q2 2026 Earnings Call
Revenue
$54.92M
▲ 22.7% YoY Diluted EPS
$0.16
▲ 23.1% YoY Gross margin
40.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-13
Kamada Ltd (KMDA) Q1 2026 Earnings Call Transcript
Confident tone
Business development and M&A
Plasma collection centers
CYTOGAM (anti-CMV) and post-marketing studies
Revenue
$45.24M
▲ 2.8% YoY Diluted EPS
$0.07
▲ 0% YoY Gross margin
42.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-11
Kamada Ltd (KMDA) Q4 2025 Earnings Call Transcript
Confident tone
2025 financial results and dividend
CYTOGAM and SHIELD study
Plasma collection centers
Revenue
$44.68M*
▲ 14.5% YoY Gross margin
38.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-09-30
Date not confirmed
Kamada Ltd (KMDA) Q3 2025 Earnings Call Transcript
Confident tone
Cytogam CMV immunoglobulin and SHIELD study
GLASSIA / alpha-1 antitrypsin (Glacia) ex-US and royalties
Plasma collection centers (Houston and San Antonio)
Revenue
$47.01M
▲ 12.6% YoY Diluted EPS
$0.09
▲ 28.6% YoY Gross margin
42.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
Date not confirmed
Kamada Ltd (KMDA) Q1 2025 Earnings Call Transcript
Confident tone
CYTOGAM Post-Marketing Research Program
Commercial Portfolio Diversification
Business Development and M&A
Revenue
$44.02M
▲ 16.6% YoY Diluted EPS
$0.07
▲ 75% YoY Gross margin
47.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q3
2024-09-30
Date not confirmed
Kamada Ltd (KMDA) Q3 2024 Earnings Call Transcript
Confident tone
Revenue and EBITDA Growth
InnovAATe Phase 3 Trial
Plasma Collection Centers Expansion
Revenue
$41.74M
▲ 10% YoY Diluted EPS
$0.07
▲ 16.7% YoY Gross margin
41.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
Date not confirmed
Kamada Ltd (KMDA) Q2 2024 Earnings Call Transcript
Confident tone
Commercial portfolio growth (KEDRAB and CYTOGAM)
Partnerships for inhaled AAT
Financial performance and profitability
Revenue
$42.47M
▲ 13.4% YoY Diluted EPS
$0.08
▲ 100% YoY Gross margin
44.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Date not confirmed
Kamada Ltd (KMDA) Q1 2024 Earnings Call Transcript
Confident tone
KEDRAB and CYTOGAM growth
Financial performance and guidance raise
Biosimilars portfolio in Israel
Revenue
$37.74M
▲ 122778.5% YoY Diluted EPS
$0.04
Gross margin
44.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Date not confirmed
Kamada Ltd (KMDA) Q4 2023 Earnings Call Transcript
Revenue
$67.11M*
▼ 13.5% YoY Gross margin
39.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-09-30
Date not confirmed
Kamada Ltd (KMDA) Q3 2023 Earnings Call Transcript
Revenue
$37.93M
▲ 117645.3% YoY Diluted EPS
$0.06
▲ 500% YoY Gross margin
39.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
Date not confirmed
Kamada Ltd (KMDA) Q2 2023 Earnings Call Transcript
Revenue
$37.44M
▲ 58.7% YoY Diluted EPS
$0.04
Gross margin
38.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
Date not confirmed
Kamada Ltd (KMDA) Q1 2023 Earnings Call Transcript
Revenue
$30,710
▼ 99.9% YoY Diluted EPS
$-0.04
Gross margin
38.6%
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Date not confirmed
Kamada Ltd (KMDA) Q4 2022 Earnings Call Transcript
Revenue
$77.62M*
Gross margin
36.3%
Rev · 6q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-09-30
Date not confirmed
Kamada Ltd (KMDA) Q3 2022 Earnings Call Transcript
Revenue
$32,217
▼ 99.9% YoY Diluted EPS
$0.01
Gross margin
39.9%
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
Date not confirmed
Kamada Ltd (KMDA) Q1 2022 Earnings Call Transcript
Revenue
$28.09M
Diluted EPS
$-0.04
Gross margin
40.2%
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2021-12-31
Date not confirmed
Kamada Ltd (KMDA) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-09-30
Date not confirmed
Kamada Ltd (KMDA) Q3 2021 Earnings Call Transcript
Revenue
$23.03M
▼ 34.8% YoY Diluted EPS
$-0.02
▼ 113.3% YoY Gross margin
24.9%
Rev · 3q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-06-30
Date not confirmed
Kamada Ltd (KMDA) Q2 2021 Earnings Call Transcript
Revenue
$24.24M
Diluted EPS
$0.02
Gross margin
37.4%
Rev · 2q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-03-31
Date not confirmed
Kamada Ltd (KMDA) Q1 2021 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2020-12-31
Date not confirmed
Kamada Ltd (KMDA) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-09-30
Date not confirmed
Kamada Ltd (KMDA) Q3 2020 Earnings Call Transcript
Revenue
$35.33M
Diluted EPS
$0.15
Gross margin
42.0%
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-06-30
Date not confirmed
Kamada Ltd (KMDA) Q2 2020 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-03-31
Date not confirmed
Kamada Ltd (KMDA) Q1 2020 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Showing 1–23 of 23 webcasts